跳至主要内容
临床试验/KCT0009226
KCT0009226招募中Unknown

The effect of intraoperative remifentanil and sufentanil TCI on postoperative pain and postoperative opioid consumption in breast cancer surgery: A randomized controlled study

Chung-Ang University Gwangmyeong Hospital0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18(Year) 至 70(Year)(—)
性别
All

入选标准

  • Adult female patient with American Society of Anesthesiologists physical status level 1-2 scheduled for breast-conserving surgery under general anesthesia

排除标准

  • - Under 18 years of age or over 70 years of age
  • - ASA 3 or higher
  • - BMI 35 or higher
  • - Pregnant and lactating women
  • - Patients with serious cardiovascular, liver, kidney, and hematological abnormalities
  • - Patients with uncontrolled respiratory disease and moderate to severe pulmonary dysfunction
  • - Those taking opioids, anticonvulsants, or antidepressants
  • - Those with a history of hypersensitivity or serious side effects to drugs related to this study (opioids, acetaminophen, tramadol)
  • - During the surgical procedure, the scope of surgery is reduced to a tumor resection or expanded to a total mastectomy.
  • - Those who refused to participate in this study

研究者

发起方
Chung-Ang University Gwangmyeong Hospital

相似试验

The effect of intraoperative remifentanil and... | 临床试验